RxDoctor Payments DataLook up a doctor →

Maria Harrington

Primary Care · Clermont, FLNPI 1619058583

Payments from drug & device makers

$6,863in general payments, 2019–2025

Across 367 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$994
  • AstraZeneca$712
  • Lilly USA, LLC$449
  • Amgen$441
  • Bayer$387
  • plus $3K from 40 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie61$1,034
Novo Nordisk74$994
AstraZeneca22$712
Lilly USA, LLC28$449
Amgen(2 entities)19$441
Bayer21$387
Pfizer10$195
Astellas Pharma US Inc6$191
Abbott10$189
Exact Sciences10$187
Johnson & Johnson7$169
Boehringer Ingelheim6$168
Corium, LLC7$152
Jazz Pharmaceuticals Inc.8$145
Sanofi-aventis U.S. LLC6$139
GSK7$139
Otsuka America Pharmaceutical, Inc.6$114
Merck6$97
Tris Pharma Inc4$71
Axsome Therapeutics, Inc.3$65
Scilex Pharmaceuticals Inc.3$60
Novartis3$56
Clarus Therapeutics Inc.3$53
Idorsia Pharmaceuticals US Inc3$51
Takeda Pharmaceuticals U.S.A., Inc.2$48
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$45
Daiichi Sankyo Inc.2$38
Phathom Pharmaceuticals, Inc.2$36
Biohaven Pharmaceutical Holding Company Ltd.2$36
Amarin Pharma, Inc.2$34
Teva Pharmaceuticals USA, Inc.2$32
Kowa Pharmaceuticals America, Inc.2$32
Esperion Therapeutics, Inc.2$32
Antares Pharma, Inc.2$30
Phadia US Inc.2$29
Acerus Pharmaceuticals Corporation2$26
Dynavax Technologies Corporation1$23
Smith+Nephew1$22
Aimmune Therapeutics, Inc.1$21
Convatec Inc.1$21
Sanofi Pasteur Inc.1$19
Biohaven Pharmaceuticals, Inc.1$19
Almatica Pharma LLC1$19
Corcept Therapeutics1$17
Tolmar, Inc.1$14
Ironshore Pharmaceuticals Inc.1$13

How this compares

$6,863 in reported general payments places this provider in the 95th percentile of 725 primary care providers in Florida.

See all primary care providers in Florida →

Medicare billing

Part B allowed, 2024
$68,718
Medicare patients
238
Services billed
887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other primary care in Clermont

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →